159 related articles for article (PubMed ID: 23099098)
1. Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity.
Guo DL; Zhang XJ; Wang RR; Zhou Y; Li Z; Xu JY; Chen KX; Zheng YT; Liu H
Bioorg Med Chem Lett; 2012 Dec; 22(23):7114-8. PubMed ID: 23099098
[TBL] [Abstract][Full Text] [Related]
2. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
Bhatt H; Patel P; Pannecouque C
Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C
Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597
[TBL] [Abstract][Full Text] [Related]
4. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
[TBL] [Abstract][Full Text] [Related]
5. 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates--a new class of HIV-1 integrase inhibitors.
Donghi M; Kinzel OD; Summa V
Bioorg Med Chem Lett; 2009 Apr; 19(7):1930-4. PubMed ID: 19269170
[TBL] [Abstract][Full Text] [Related]
6. Multivariate QSAR study of 4,5-dihydroxypyrimidine carboxamides as HIV-1 integrase inhibitors.
de Melo EB; Ferreira MM
Eur J Med Chem; 2009 Sep; 44(9):3577-83. PubMed ID: 19327872
[TBL] [Abstract][Full Text] [Related]
7. Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase.
Zhang D; Debnath B; Yu S; Sanchez TW; Christ F; Liu Y; Debyser Z; Neamati N; Zhao G
Bioorg Med Chem; 2014 Oct; 22(19):5446-53. PubMed ID: 25150089
[TBL] [Abstract][Full Text] [Related]
8. Design of a series of bicyclic HIV-1 integrase inhibitors. Part 1: selection of the scaffold.
Jones ED; Vandegraaff N; Le G; Choi N; Issa W; Macfarlane K; Thienthong N; Winfield LJ; Coates JA; Lu L; Li X; Feng X; Yu C; Rhodes DI; Deadman JJ
Bioorg Med Chem Lett; 2010 Oct; 20(19):5913-7. PubMed ID: 20727748
[TBL] [Abstract][Full Text] [Related]
9. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
[TBL] [Abstract][Full Text] [Related]
10. Design and optimization of tricyclic phtalimide analogues as novel inhibitors of HIV-1 integrase.
Verschueren WG; Dierynck I; Amssoms KI; Hu L; Boonants PM; Pille GM; Daeyaert FF; Hertogs K; Surleraux DL; Wigerinck PB
J Med Chem; 2005 Mar; 48(6):1930-40. PubMed ID: 15771437
[TBL] [Abstract][Full Text] [Related]
11. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
[TBL] [Abstract][Full Text] [Related]
12. Dihydroxy-pyrimidine and N-methylpyrimidone HIV-integrase inhibitors: improving cell based activity by the quaternarization of a chiral center.
Nizi E; Orsale MV; Crescenzi B; Pescatore G; Muraglia E; Alfieri A; Gardelli C; Spieser SA; Summa V
Bioorg Med Chem Lett; 2009 Aug; 19(16):4617-21. PubMed ID: 19616948
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
[TBL] [Abstract][Full Text] [Related]
14. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
[TBL] [Abstract][Full Text] [Related]
15. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
Sechi M; Rizzi G; Bacchi A; Carcelli M; Rogolino D; Pala N; Sanchez TW; Taheri L; Dayam R; Neamati N
Bioorg Med Chem; 2009 Apr; 17(7):2925-35. PubMed ID: 19026554
[TBL] [Abstract][Full Text] [Related]
17. New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action.
Ferro S; De Luca L; Barreca ML; De Grazia S; Christ F; Debyser Z; Chimirri A
Bioorg Med Chem; 2010 Aug; 18(15):5510-8. PubMed ID: 20630765
[TBL] [Abstract][Full Text] [Related]
18. Exploration of novel thiobarbituric acid-, rhodanine- and thiohydantoin-based HIV-1 integrase inhibitors.
Rajamaki S; Innitzer A; Falciani C; Tintori C; Christ F; Witvrouw M; Debyser Z; Massa S; Botta M
Bioorg Med Chem Lett; 2009 Jul; 19(13):3615-8. PubMed ID: 19447621
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor.
Yang L; Xu X; Huang Y; Zhang B; Zeng C; He H; Wang C; Hu L
Bioorg Med Chem Lett; 2010 Sep; 20(18):5469-71. PubMed ID: 20709544
[TBL] [Abstract][Full Text] [Related]
20. 6-Benzoyl-3-hydroxypyrimidine-2,4-diones as dual inhibitors of HIV reverse transcriptase and integrase.
Tang J; Maddali K; Dreis CD; Sham YY; Vince R; Pommier Y; Wang Z
Bioorg Med Chem Lett; 2011 Apr; 21(8):2400-2. PubMed ID: 21392991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
